Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Complications Associated With Nitrate Use in Patients Presenting With Acute Pulmonary Edema and Concomitant Moderate or Severe Aortic Stenosis.

Claveau D, Piha-Gossack A, Friedland SN, Afilalo J, Rudski L.

Ann Emerg Med. 2015 Oct;66(4):355-362.e1. doi: 10.1016/j.annemergmed.2015.03.027. Epub 2015 May 19.

PMID:
26002298
2.

[Defending the promotion of clinical judgement].

Voyer P, Mercier J, Roy S, Claveau D, Kasprzak L, Lépine H, Mignault J, Rey S, Fortin MC, Desrochers A, Wilchesky M, Tremblay L, Savoie M, Roy O, Morin D.

Perspect Infirm. 2014 Sep-Oct;11(4):27-32. French. No abstract available.

PMID:
25269236
3.

Detection of Listeria spp. using ACTERO listeria enrichment media.

Claveau D, Olishevskyy S, Giuffre M, Martinez G.

J AOAC Int. 2014 Jul-Aug;97(4):1127-36.

PMID:
25145148
5.

Cardiac tamponade due to group a streptococcus descending necrotizing mediastinitis: case report of an unusual presentation.

Claveau D, Bériault MJ.

J Emerg Med. 2014 Jul;47(1):12-4. doi: 10.1016/j.jemermed.2014.01.024. Epub 2014 Mar 20.

PMID:
24657258
6.

Gene expression profiling following NRF2 and KEAP1 siRNA knockdown in human lung fibroblasts identifies CCL11/Eotaxin-1 as a novel NRF2 regulated gene.

Fourtounis J, Wang IM, Mathieu MC, Claveau D, Loo T, Jackson AL, Peters MA, Therien AG, Boie Y, Crackower MA.

Respir Res. 2012 Oct 12;13:92. doi: 10.1186/1465-9921-13-92.

7.

Broadening the spectrum of β-lactam antibiotics through inhibition of signal peptidase type I.

Therien AG, Huber JL, Wilson KE, Beaulieu P, Caron A, Claveau D, Deschamps K, Donald RG, Galgoci AM, Gallant M, Gu X, Kevin NJ, Lafleur J, Leavitt PS, Lebeau-Jacob C, Lee SS, Lin MM, Michels AA, Ogawa AM, Painter RE, Parish CA, Park YW, Benton-Perdomo L, Petcu M, Phillips JW, Powles MA, Skorey KI, Tam J, Tan CM, Young K, Wong S, Waddell ST, Miesel L.

Antimicrob Agents Chemother. 2012 Sep;56(9):4662-70. doi: 10.1128/AAC.00726-12. Epub 2012 Jun 18.

8.

Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics.

Tan CM, Therien AG, Lu J, Lee SH, Caron A, Gill CJ, Lebeau-Jacob C, Benton-Perdomo L, Monteiro JM, Pereira PM, Elsen NL, Wu J, Deschamps K, Petcu M, Wong S, Daigneault E, Kramer S, Liang L, Maxwell E, Claveau D, Vaillancourt J, Skorey K, Tam J, Wang H, Meredith TC, Sillaots S, Wang-Jarantow L, Ramtohul Y, Langlois E, Landry F, Reid JC, Parthasarathy G, Sharma S, Baryshnikova A, Lumb KJ, Pinho MG, Soisson SM, Roemer T.

Sci Transl Med. 2012 Mar 21;4(126):126ra35. doi: 10.1126/scitranslmed.3003592.

9.

High-frequency transposition for determining antibacterial mode of action.

Wang H, Claveau D, Vaillancourt JP, Roemer T, Meredith TC.

Nat Chem Biol. 2011 Sep 4;7(10):720-9. doi: 10.1038/nchembio.643.

PMID:
21892185
10.

Trisubstituted ureas as potent and selective mPGES-1 inhibitors.

Chiasson JF, Boulet L, Brideau C, Chau A, Claveau D, Côté B, Ethier D, Giroux A, Guay J, Guiral S, Mancini J, Massé F, Méthot N, Riendeau D, Roy P, Rubin J, Xu D, Yu H, Ducharme Y, Friesen RW.

Bioorg Med Chem Lett. 2011 Mar 1;21(5):1488-92. doi: 10.1016/j.bmcl.2011.01.006. Epub 2011 Jan 13.

PMID:
21295979
11.

Discovery of disubstituted phenanthrene imidazoles as potent, selective and orally active mPGES-1 inhibitors.

Giroux A, Boulet L, Brideau C, Chau A, Claveau D, Côté B, Ethier D, Frenette R, Gagnon M, Guay J, Guiral S, Mancini J, Martins E, Massé F, Méthot N, Riendeau D, Rubin J, Xu D, Yu H, Ducharme Y, Friesen RW.

Bioorg Med Chem Lett. 2009 Oct 15;19(20):5837-41. doi: 10.1016/j.bmcl.2009.08.085. Epub 2009 Aug 28.

PMID:
19748780
12.

Alkyl-bridged substituted 8-arylquinolines as highly potent PDE IV inhibitors.

Lacombe P, Chauret N, Claveau D, Day S, Deschênes D, Dubé D, Gallant M, Girard Y, Huang Z, Laliberté F, Lévesque JF, Liu S, Macdonald D, Mancini JA, Masson P, Nicholson DW, Nicoll-Griffith DA, Salem M, Styhler A, Young RN.

Bioorg Med Chem Lett. 2009 Sep 1;19(17):5266-9. doi: 10.1016/j.bmcl.2009.03.105. Epub 2009 Mar 26.

PMID:
19640717
13.

Design, synthesis, and biological evaluation of 8-biarylquinolines: a novel class of PDE4 inhibitors.

Gallant M, Chauret N, Claveau D, Day S, Deschênes D, Dubé D, Huang Z, Lacombe P, Laliberté F, Lévesque JF, Liu S, Macdonald D, Mancini J, Masson P, Mastracchio A, Nicholson D, Nicoll-Griffith DA, Perrier H, Salem M, Styhler A, Young RN, Girard Y.

Bioorg Med Chem Lett. 2008 Feb 15;18(4):1407-12. doi: 10.1016/j.bmcl.2008.01.004. Epub 2008 Jan 8.

PMID:
18207397
14.

Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors.

Côté B, Boulet L, Brideau C, Claveau D, Ethier D, Frenette R, Gagnon M, Giroux A, Guay J, Guiral S, Mancini J, Martins E, Massé F, Méthot N, Riendeau D, Rubin J, Xu D, Yu H, Ducharme Y, Friesen RW.

Bioorg Med Chem Lett. 2007 Dec 15;17(24):6816-20. Epub 2007 Oct 17.

PMID:
18029174
15.

L-454,560, a potent and selective PDE4 inhibitor with in vivo efficacy in animal models of asthma and cognition.

Huang Z, Dias R, Jones T, Liu S, Styhler A, Claveau D, Otu F, Ng K, Laliberte F, Zhang L, Goetghebeur P, Abraham WM, Macdonald D, Dubé D, Gallant M, Lacombe P, Girard Y, Young RN, Turner MJ, Nicholson DW, Mancini JA.

Biochem Pharmacol. 2007 Jun 15;73(12):1971-81. Epub 2007 Mar 16.

PMID:
17428447
16.

Discovery of a substituted 8-arylquinoline series of PDE4 inhibitors: structure-activity relationship, optimization, and identification of a highly potent, well tolerated, PDE4 inhibitor.

Macdonald D, Mastracchio A, Perrier H, Dubé D, Gallant M, Lacombe P, Deschênes D, Roy B, Scheigetz J, Bateman K, Li C, Trimble LA, Day S, Chauret N, Nicoll-Griffith DA, Silva JM, Huang Z, Laliberté F, Liu S, Ethier D, Pon D, Muise E, Boulet L, Chan CC, Styhler A, Charleson S, Mancini J, Masson P, Claveau D, Nicholson D, Turner M, Young RN, Girard Y.

Bioorg Med Chem Lett. 2005 Dec 1;15(23):5241-6. Epub 2005 Sep 15.

PMID:
16168647
17.
18.
19.

Pyridazinones as selective cyclooxygenase-2 inhibitors.

Li CS, Brideau C, Chan CC, Savoie C, Claveau D, Charleson S, Gordon R, Greig G, Gauthier JY, Lau CK, Riendeau D, Thérien M, Wong E, Prasit P.

Bioorg Med Chem Lett. 2003 Feb 24;13(4):597-600.

PMID:
12639538
20.

Comparison of inhibition of ovalbumin-induced bronchoconstriction in guinea pigs and in vitro inhibition of tumor necrosis factor-alpha formation with phosphodiesterase 4 (PDE4) selective inhibitors.

Muise ES, Chute IC, Claveau D, Masson P, Boulet L, Tkalec L, Pon DJ, Girard Y, Frenette R, Mancini JA.

Biochem Pharmacol. 2002 Apr 15;63(8):1527-35.

PMID:
11996895
21.

Visual observation is a valid means of assessing dietary consumption among older adults with cognitive deficits in long-term care settings.

Shatenstein B, Claveau D, Ferland G.

J Am Diet Assoc. 2002 Feb;102(2):250-2. No abstract available.

PMID:
11846121
22.

Roles of ATP and cytoskeleton in the regulation of Na+/H+ exchanger along the nephron luminal membrane.

Pellerin I, Leclerc M, Claveau D, Mailloux J, Brunette MG.

J Cell Physiol. 2001 Apr;187(1):109-16.

PMID:
11241355
23.

Mutations of the C-terminal end of cathepsin K affect proenzyme secretion and intracellular maturation.

Claveau D, Riendeau D.

Biochem Biophys Res Commun. 2001 Feb 23;281(2):551-7.

PMID:
11181082
24.

Cloning, expression, and up-regulation of inducible rat prostaglandin e synthase during lipopolysaccharide-induced pyresis and adjuvant-induced arthritis.

Mancini JA, Blood K, Guay J, Gordon R, Claveau D, Chan CC, Riendeau D.

J Biol Chem. 2001 Feb 9;276(6):4469-75. Epub 2000 Nov 6.

25.

Expression, maturation, and rhodamine-based fluorescence assay of human cathepsin K expressed in CHO cells.

Claveau D, Riendeau D, Mancini JA.

Biochem Pharmacol. 2000 Sep 15;60(6):759-69.

PMID:
10930530
26.

A new structural variation on the methanesulfonylphenyl class of selective cyclooxygenase-2 inhibitors.

Li CS, Black WC, Brideau C, Chan CC, Charleson S, Cromlish WA, Claveau D, Gauthier JY, Gordon R, Greig G, Grimm E, Guay J, Lau CK, Riendeau D, Thérien M, Visco DM, Wong E, Xu L, Prasit P.

Bioorg Med Chem Lett. 1999 Nov 15;9(22):3181-6.

PMID:
10576684
27.

Inhibition of cathepsin K by nitric oxide donors: evidence for the formation of mixed disulfides and a sulfenic acid.

Percival MD, Ouellet M, Campagnolo C, Claveau D, Li C.

Biochemistry. 1999 Oct 12;38(41):13574-83.

PMID:
10521264
28.

2,3-Diarylcyclopentenones as orally active, highly selective cyclooxygenase-2 inhibitors.

Black WC, Brideau C, Chan CC, Charleson S, Chauret N, Claveau D, Ethier D, Gordon R, Greig G, Guay J, Hughes G, Jolicoeur P, Leblanc Y, Nicoll-Griffith D, Ouimet N, Riendeau D, Visco D, Wang Z, Xu L, Prasit P.

J Med Chem. 1999 Apr 8;42(7):1274-81.

PMID:
10197970
29.

Substituted heterocyclic analogs as selective COX-2 inhibitors in the flosulide class.

Ouimet N, Chan CC, Charleson S, Claveau D, Gordon R, Guay D, Li CS, Ouellet M, Percival DM, Riendeau D, Wong E, Zamboni R, Prasit P.

Bioorg Med Chem Lett. 1999 Jan 18;9(2):151-6.

PMID:
10021918
30.

Characterization of the Na+/H+ exchanger in the luminal membrane of the distal nephron.

Claveau D, Pellerin I, Leclerc M, Brunette MG.

J Membr Biol. 1998 Oct 1;165(3):265-74.

PMID:
9767680
31.

Ca2+ transport by the luminal membrane of the distal nephron: action and interaction of protein kinases A and C.

Hilal G, Claveau D, Leclerc M, Brunette MG.

Biochem J. 1997 Dec 1;328 ( Pt 2):371-5.

32.

Effect of calcitonin on calcium transport by the luminal and basolateral membranes of the rabbit nephron.

Zuo Q, Claveau D, Hilal G, Leclerc M, Brunette MG.

Kidney Int. 1997 Jun;51(6):1991-9.

33.

Na+ transport by human placental brush border membranes: are there several mechanisms?

Brunette MG, Leclerc, Claveau D.

J Cell Physiol. 1996 Apr;167(1):72-80.

PMID:
8698842

Supplemental Content

Loading ...
Support Center